BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khurana A, Hartmann P. Gut microbiome-specific nanoparticle-based therapeutics for liver diseases. World J Gastroenterol 2025; 31(27): 109105 [PMID: 40741099 DOI: 10.3748/wjg.v31.i27.109105]
URL: https://www.wjgnet.com/1007-9327/full/v31/i27/109105.htm
Number Citing Articles
1
Bakr Ahmed Taha, Ali J. Addie, Luai Farhan Zghair Kolie, Saba Talib Wahhab, Sinan Adnan Abdulateef, Adawiya J. Haider, Khalid Ibnaouf, Norhana Arsad. Advancements in nanophotonics and smart nanomaterials integrated with artificial intelligence-driven gene editing: A paradigm shift in cancer diagnosis and therapeuticChinese Chemical Letters 2026; 37(4): 111955 doi: 10.1016/j.cclet.2025.111955
2
Jiuba Zhang, Yanan Zhou, Xi Mei, Shuai Yan, Jing Mao, Yu Li, Zhenhua Bian, Lin Li, De Ji, Tulin Lu, Juxiang Chen, Lianlin Su. Molecular mechanisms and therapeutic potential of tryptophan metabolism in gut-brain signaling transduction: a narrative reviewJournal of Neuroinflammation 2026;  doi: 10.1186/s12974-026-03763-w
3
Khadijah Zai. The bidirectional interface between oral drug and the gut microbiome: Implications for drug deliveryPharmaceutical Science Advances 2026; 4: 100112 doi: 10.1016/j.pscia.2026.100112
4
Jing Chen, Mingliao Niu, Longjiang Zhang. Gut microbiota in hepatic encephalopathy: a 3PM-guided three-tier health strategyEPMA Journal 2025; 17(1): 135 doi: 10.1007/s13167-025-00433-4
5
Chun-Ye Zhang, Shuai Liu, Yu-Xiang Sui, Ming Yang. Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitisWorld Journal of Hepatology 2025; 17(11): 113756 doi: 10.4254/wjh.v17.i11.113756